Codiak BioSciences, Inc. Increase (Decrease) in Accrued Liabilities
Codiak BioSciences, Inc. reported Increase (Decrease) in Accrued Liabilities of -$1.73 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2022-11-03
- Codiak BioSciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was $175.00K, a 88.90% decline year-over-year.
- Codiak BioSciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was $960.00K, a 22.39% decline year-over-year.
- Codiak BioSciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was -$2.86M.
- Codiak BioSciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-12-31 was -$256.00K.
- Codiak BioSciences, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was $862.00K.
- Codiak BioSciences, Inc. increase (decrease) in accrued liabilities for fiscal 2020 was -$3.98M, a 147.93% decline from fiscal 2019.
- Codiak BioSciences, Inc. increase (decrease) in accrued liabilities for fiscal 2019 was $8.31M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2022-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.14M derived: sum of 2 quarters · filed 2022-11-03 | -$1.73M 10-Q · filed 2022-11-03 | -$1.98M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $960.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.90M 10-Q · filed 2022-08-04 | -$2.16M derived: sum of 3 quarters · filed 2022-08-04 | -$579.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | -$2.86M 10-Q · filed 2022-05-05 | -$3.12M derived: sum of 2 quarters · filed 2022-05-05 | -$1.54M derived: sum of 3 quarters · filed 2022-11-03 | -$302.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | -$256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.32M derived: sum of 2 quarters · filed 2022-11-03 | $2.56M derived: sum of 3 quarters · filed 2022-11-03 | $862.00K 10-K · filed 2022-03-10 |
| 2021-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.81M derived: sum of 2 quarters · filed 2022-11-03 | $1.12M 10-Q · filed 2022-11-03 | -$13.58M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$459.00K 10-Q · filed 2022-08-04 | -$15.16M derived: sum of 3 quarters · filed 2022-08-04 | $472.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$1.70M 10-Q · filed 2022-05-05 | -$16.40M derived: sum of 2 quarters · filed 2022-05-05 | -$765.00K derived: sum of 3 quarters · filed 2022-05-05 | -$1.37M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $931.00K derived: sum of 2 quarters · filed 2022-03-10 | $330.00K derived: sum of 3 quarters · filed 2022-03-10 | -$3.98M 10-K · filed 2022-03-10 |
| 2020-09-30 | $15.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $15.03M derived: sum of 2 quarters · filed 2021-11-04 | $10.71M 10-Q · filed 2021-11-04 | $13.07M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$601.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$4.92M 10-Q · filed 2021-08-05 | -$2.56M derived: sum of 3 quarters · filed 2021-08-05 | |
| 2020-03-31 | -$4.32M 10-Q · filed 2021-05-06 | -$1.96M derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $8.31M 10-K · filed 2021-03-17 | ||
| 2019-09-30 | $5.96M 10-Q · filed 2020-11-19 |